M. R. Mattern

Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.

M. Mattern, C. Mirabelli, N. Hanna, 1990, Cancer research.

Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.

R. Hertzberg, G. Hofmann, M. Mattern, 1992, Oncology research.

Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.

K. Kohn, Y. Pommier, L. Zwelling, 1986, Cancer research.

Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

D. Sullivan, W. Ross, S. Crooke, 1987, The Journal of biological chemistry.